Ilan Ganot is CEO & President at Solid Biosciences Inc. (SLDB). They have made 16 open-market trades across 1 company since 2018, most recently 2026-02-18.
CIK 0001727460
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SLDB | 30,132 | $196K |
Shares reported on the most recent Form 4, priced at the 2026-02-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLDB | SELL | 2026-02-18 | 2026-02-18 | $5.82 | $15K | +6.7% | +20.5% | +4.7% |
| SLDB | SELL | 2026-02-04 | 2026-02-06 | $6.44 | $46K | -10.5% | +22.1% | +7.7% |
| SLDB | SELL | 2026-01-28 | 2026-01-30 | $6.59 | $1K | +0.0% | -3.1% | +13.3% |
| SLDB | SELL | 2026-01-05 | 2026-01-06 | $5.43 | $6K | -0.7% | +13.1% | +40.4% |
| SLDB | SELL | 2025-11-10 | 2025-11-13 | $4.12 | $14K | +18.9% | +31.9% | +47.8% |
| SLDB | SELL | 2025-02-14 | 2025-02-18 | $3.96 | $7K | +2.6% | -13.8% | -46.8% |
| SLDB | SELL | 2025-01-28 | 2025-01-29 | $3.11 | $448 | +2.7% | +66.9% | -9.0% |
| SLDB | SELL | 2025-01-06 | 2025-01-07 | $4.31 | $5K | -27.4% | -30.3% | -34.5% |
| SLDB | SELL | 2024-05-02 | 2024-05-06 | $10.33 | $5K | -6.7% | -22.1% | -22.3% |
| SLDB | SELL | 2024-01-29 | 2024-01-30 | $7.99 | $1K | -2.6% | +17.5% | +10.0% |
| SLDB | SELL | 2024-01-03 | 2024-01-05 | $5.30 | $6K | +21.5% | +9.5% | +100.3% |
| SLDB | SELL · 10b5-1 | 2023-05-02 | 2023-06-08 | $4.85 | $2K | -2.4% | -16.1% | -45.1% |
| SLDB | SELL · 10b5-1 | 2023-01-27 | 2023-01-31 | $7.49 | $11K | -7.7% | -28.8% | -29.8% |
| SLDB | SELL · 10b5-1 | 2022-02-10 | 2022-03-08 | $1.12 | $519 | +84.4% | +57.1% | -22.1% |
| SLDB | SELL | 2021-02-12 | 2021-02-16 | $7.66 | $4K | +10.5% | -16.1% | -50.8% |
| SLDB | SELL | 2021-01-28 | 2021-01-29 | $6.14 | $132K | +25.3% | +30.7% | -20.6% |
| SLDB | SELL | 2020-08-13 | 2020-08-14 | $2.44 | $730 | -13.0% | -10.5% | +15.2% |
| SLDB | SELL | 2020-07-28 | 2020-07-29 | $2.42 | $27K | +10.7% | -2.9% | +38.9% |
| SLDB | SELL | 2018-11-15 | 2018-11-19 | $30.84 | $1.5M | -3.1% | -30.7% | -74.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.